Angiomyolipoma differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 10: | Line 10: | ||
*Adrenal myelolipoma | *Adrenal myelolipoma | ||
*Renal cell carcinoma (RCC) | *Renal cell carcinoma (RCC) | ||
** | **May contain fat: lipid necrosis or osseous metaplasia | ||
*Oncocytoma: may contain fat | *Oncocytoma: may contain fat | ||
*Wilms tumour: may contain fat | *Wilms tumour: may contain fat |
Revision as of 16:03, 21 September 2015
Angiomyolipoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Angiomyolipoma differential diagnosis On the Web |
American Roentgen Ray Society Images of Angiomyolipoma differential diagnosis |
Risk calculators and risk factors for Angiomyolipoma differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Faizan Sheraz, M.D. [2]
When an AML has typical appearances there is essentially no differential. If atypical, especially when fat-poor other lesions to consider include:
- Retroperitoneal liposarcoma invading the kidney:
- Presence of a large vessel extending into the renal cortex suggestive of AML; liposarcoma is hypovascular
- Renal parenchymal defect at the site of tumour contact favours exophytic angiomyolipoma- claw sign
- Calcifications suggest liposarcoma
- Adrenal myelolipoma
- Renal cell carcinoma (RCC)
- May contain fat: lipid necrosis or osseous metaplasia
- Oncocytoma: may contain fat
- Wilms tumour: may contain fat
- Perirenal fat entrapment / renal junctional parenchymal defect